Chinese Blood Disease Drugs Industry Discussed in New AMID Research Report Now Available at

29 Sep 2015 • by Natalie Aster

LONDON – The Chinese industry has demonstrated swift growth over the last twenty years. With considerable manufacturing capabilities’ expansion and an increase in consumption, the local economy and society have undergone transformation.

Currently, the country is amongst key world’s producers of consumer and industrial products. It is also the swiftest growing market for consumer goods and services.

However, low investments in R&D and development of new products as well as minima innovation retrain growth of the industry. Besides, a large number of local producers do not have enough financial resources and autonomic intellectual property required for developing their own brand name products.

New research study “Blood Disease Drugs Industry Forecasts - China Focus” elaborated by AMID Co., LLC offers an up-close look at the Chinese market for blood disease drugs. The report provides a detailed overview of the marketplace. It focuses on demand trends across different regions. The study sheds light on performance of each market segment. The research report investigates pricing trends. It contains historical information and forecast data for the years to come.

Report Details:

Blood Disease Drugs Industry Forecasts - China Focus
Published: September, 2015
Pages: 97
Price: US$ 1,000.00

More new reports by the publisher are available at AMID page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970